1.

Record Nr.

UNINA9910795726603321

Autore

Taylor Suzanne <1909-2004, >

Titolo

Remedicalizing cannabis : science, industry, and drug policy / / Suzanne Taylor

Pubbl/distr/stampa

London, England : , : McGill-Queen's University Press, , [2022]

©2022

ISBN

0-2280-1350-X

0-2280-1349-6

Edizione

[1st ed.]

Descrizione fisica

1 online resource (305 pages)

Collana

Intoxicating Histories

Disciplina

362.295561

Soggetti

Cannabis - Government policy - Great Britain - History - 20th century

Cannabis - Government policy - Great Britain - History - 21st century

Cannabis - Therapeutic use - Great Britain - History - 20th century

Cannabis - Therapeutic use - Great Britain - History - 21st century

Marijuana industry - Great Britain - History - 20th century

Marijuana industry - Great Britain - History - 21st century

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Front Matter -- Contents -- Figures -- Acknowledgements -- Abbreviations -- Introduction -- Understanding Cannabis: Pharmacology, Laboratory Research, and Drug Control, 1964–82 -- Cannabis in the Clinic: Clinical Pharmacology and the Therapeutic Applications of Cannabis, 1973–82 -- Evidence-Based Policy? The Development of Expert Committees, 1972–82 -- Industrializing Cannabis: The Pharmaceutical Industry and the Remedicalization of Cannabis, 1973–2001 -- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis, 1973–2001 -- Establishing Therapeutic Cannabis: The Role of Expert Advice, 1997–2001 -- From Anecdotal to Evidence-Based Medicine: The Role of Clinical Trials, 1995–2005 -- Accessing Cannabis-Based Medicinal Products, 2009–21 -- Conclusion -- Notes -- Bibliography -- Index

Sommario/riassunto

Remedicalizing Cannabis discovers the historical ins and outs of cannabis as a botanical product with medical applications. Addressing questions about patient access, the effectiveness of international drug



control systems, and the role of expert advice, it reveals how we have arrived at the current classification of cannabis as a medical product.